Hepatitis B virus screening in patients with non-Hodgkin lymphoma in clinical practice in Poland – a report of the Polish Lymphoma Research Group

INTRODUCTION: The risk of HBV reactivation is important in lymphoma patients receiving immunosuppressive chemotherapy containing steroids or anti-CD20 antibodies. We aimed to establish the prevalence of HBV Ag and anti-HBc serologic positive results in patients with non-Hodgkin lymphoma (NHL) and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalinka, Ewa, Drozd-Sokołowska, Joanna, Waszczuk-Gajda, Anna, Barankiewicz, Joanna, Zalewska, Elżbieta, Symonowicz, Igor, Lech-Marańda, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963131/
https://www.ncbi.nlm.nih.gov/pubmed/32051719
http://dx.doi.org/10.5114/aoms.2019.86761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963131/
https://www.ncbi.nlm.nih.gov/pubmed/32051719
http://dx.doi.org/10.5114/aoms.2019.86761

Ejemplares similares